Arcadis NV (ARCADA.XC)
| Previous close | 59.95 |
| Open | 60.25 |
| Bid | 58.75 x 0 |
| Ask | 59.75 x 0 |
| Day's range | 59.95 - 59.95 |
| 52-week range | 37.68 - 61.88 |
| Volume | |
| Avg. volume | 40 |
| Market cap | 5.394B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 33.68 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.85 (1.42%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | N/A |
- Simply Wall St.
Arcadis And Two More Stocks On Euronext Amsterdam That May Be Priced Below Estimated Value
As global markets experience fluctuations and various regions show mixed economic signals, the Netherlands' stock market presents unique opportunities for investors looking for value. Amidst broader European economic uncertainties and varying monetary policies, identifying stocks that may be undervalued could offer potential benefits in the current market environment. In this context, understanding key characteristics such as solid fundamentals, strategic positioning within their sectors, and...
- Simply Wall St.
Top 3 Stocks Estimated To Be Undervalued On Euronext Amsterdam In June 2024
As European markets show signs of recovery with easing political uncertainties and a brighter monetary policy outlook, investors are turning their attention to potentially undervalued opportunities. In this context, identifying stocks on the Euronext Amsterdam that appear undervalued could be particularly timely for those looking to diversify or enhance their portfolios in June 2024.
- Simply Wall St.
Exploring Undervalued Stocks On Euronext Amsterdam With Intrinsic Discounts Ranging From 19% To 49.2%
As global markets exhibit varied responses to economic signals, the Netherlands' stock market presents unique opportunities for investors seeking value. In light of current market conditions, identifying stocks that appear undervalued relative to their intrinsic worth could be particularly compelling.
